Laura Soucek

Laura Soucek has a diverse and extensive work experience in the field of cancer research and molecular biology. Laura is currently a member of referentsfemenins.cat. Previously, they held positions at Vall d'Hebron Institute of Oncology (VHIO) as the Director of the Preclinical and Translational Research Program and as the Head of Models of Cancer Therapies Laboratory. Laura is also a Research Professor at ICREA. In addition, Laura Soucek is the Founder and Chief Executive Officer of Peptomyc, a company focused on developing cancer therapies. Laura has also served as an Associate Professor at Universitat Autònoma de Barcelona. Earlier in their career, they worked as a Research Assistant Molecular Biologist at UCSF, Comprehensive Cancer Center and as a Postdoc at UCSF. Laura also worked as a Molecular Biologist at Istituto di Biologia e Patologia Molecolari, Roma and as a PhD student (Genetics and Molecular Biology) at University La Sapienza, Roma, Italy.

Laura Soucek has a diverse education history. In 2020, they completed "The Pharma Business Development" course at CELforPharma, specializing in business development. In 2018, they also pursued an advanced business development course at EBD Academy. Earlier in their academic journey, they obtained a PhD in Genetics and Molecular Biology from Sapienza Università di Roma between 1997 and 2000. Prior to that, they earned their University Degree in Biology, with a specialization in Biotechnology, from the same institution between 1991 and 1996. Laura'seducational background began with a Maturita' Classica received from Liceo Classico A. Mancinelli in 1991. Additionally, they have taken "The Pharmaceutical Out-licensing Course" at CELforPharma, but the duration and specific field of study are not provided.